Skip to main content

and
  1. Article

    Open Access

    Dual anti-HER2/EGFR inhibition synergistically increases therapeutic effects and alters tumor oxygenation in HNSCC

    Epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), and hypoxia are associated with radioresistance. The goal of this study is to study the synergy of anti-HER2, trastuzum...

    Patrick N. Song, Shannon E. Lynch, Chloe T. DeMellier, Ameer Mansur in Scientific Reports (2024)